ABDXFAbingdon Health Ltd.

About Abingdon Health Ltd. (ABDXF)

Abingdon Health Ltd. (ABDXF) is a Diagnostics & Research company headquartered in York, United Kingdom whose shares trade over-the-counter on the Pink tier.

Abingdon Health is a world leading developer and manufacturer of high-quality rapid tests across all industry sectors, including healthcare and COVID-19. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and has also developed and marketed its own labelled tests. The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx®, a customizable image capturing technology that transforms a smartphone into a self-sufficient, standalone lateral-flow reader.

ABDXF key facts

Ticker symbol

ABDXF

Market tier

Pink

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

York, United Kingdom

Country of incorporation

GB

Estimated market cap

$18.40M (as of May 9, 2025)

Shares outstanding

262,926,110

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Not Available

Fiscal year end

6/30

Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with A